John Overdeck’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.5M | Buy |
2,135,582
+557,421
| +35% | +$2.99M | 0.01% | 1487 |
|
|
2026
Q1 | $8.52M | Sell |
1,578,161
-84,519
| -5% | -$506K | 0.01% | 1523 |
|
|
2025
Q4 | $11.6M | Buy |
1,662,680
+1,010,054
| +155% | +$6.64M | 0.02% | 1028 |
|
|
2025
Q3 | $4.21M | Buy |
652,626
+458,997
| +237% | +$3.14M | 0.01% | 1590 |
|
|
2025
Q2 | $1.29M | Sell |
193,629
-49,660
| -20% | -$255K | ﹤0.01% | 2105 |
|
|
2025
Q1 | $1.57M | Sell |
243,289
-22,172
| -8% | -$159K | ﹤0.01% | 1895 |
|
|
2024
Q4 | $2.14M | Buy |
265,461
+231,781
| +688% | +$1.91M | ﹤0.01% | 1664 |
|
|
2024
Q3 | $275K | Buy |
+33,680
| New | +$222K | ﹤0.01% | 2704 |
|
|
2022
Q4 | – | Sell |
-261,078
| Closed | -$1.8M | – | 2808 |
|
|
2022
Q3 | $1.8M | Buy |
261,078
+114,478
| +78% | +$795K | 0.01% | 1200 |
|
|
2022
Q2 | $1.23M | Sell |
146,600
-485,272
| -77% | -$6.78M | ﹤0.01% | 1455 |
|
|
2022
Q1 | $14.4M | Buy |
631,872
+607,341
| +2,476% | +$14.8M | 0.04% | 484 |
|
|
2021
Q4 | $677K | Sell |
24,531
-175,766
| -88% | -$4.71M | ﹤0.01% | 2934 |
|
|
2021
Q3 | $5.58M | Sell |
200,297
-1,104,635
| -85% | -$31.3M | 0.01% | 1154 |
|
|
2021
Q2 | $38.3M | Sell |
1,304,932
-770,948
| -37% | -$23.4M | 0.09% | 273 |
|
|
2021
Q1 | $65.9M | Buy |
2,075,880
+1,165,958
| +128% | +$34.2M | 0.17% | 122 |
|
|
2020
Q4 | $18.9M | Buy |
+909,922
| New | +$17M | 0.05% | 393 |
|
|
2020
Q2 | – | Sell |
-14,924
| Closed | -$231K | – | 2949 |
|
|
2020
Q1 | $231K | Sell |
14,924
-998,257
| -99% | -$24.1M | ﹤0.01% | 2547 |
|
|
2019
Q4 | $30.3M | Buy |
+1,013,181
| New | +$26.3M | 0.09% | 263 |
|
|
2019
Q3 | – | Sell |
-853,761
| Closed | -$21.5M | – | 3453 |
|
|
2019
Q2 | $21.5M | Sell |
853,761
-1,565,732
| -65% | -$37.2M | 0.07% | 337 |
|
|
2019
Q1 | $59.8M | Buy |
2,419,493
+1,297,869
| +116% | +$31M | 0.19% | 128 |
|
|
2018
Q4 | $20.7M | Buy |
1,121,624
+436,196
| +64% | +$10.4M | 0.08% | 326 |
|
|
2018
Q3 | $17.6M | Sell |
685,428
-47,480
| -6% | -$1.09M | 0.05% | 456 |
|
|
2018
Q2 | $17M | Buy |
+732,908
| New | +$15.2M | 0.05% | 466 |
|
|
2018
Q1 | – | Sell |
-2,753,652
| Closed | -$57.2M | – | 3147 |
|
|
2017
Q4 | $57.2M | Buy |
+2,753,652
| New | +$43.7M | 0.19% | 146 |
|
|
2017
Q3 | – | Sell |
-712,674
| Closed | -$12.3M | – | 2746 |
|
|
2017
Q2 | $12.3M | Buy |
+712,674
| New | +$8.54M | 0.04% | 451 |
|
|
2017
Q1 | – | Sell |
-538,803
| Closed | -$7.82M | – | 2906 |
|
|
2016
Q4 | $7.82M | Buy |
+538,803
| New | +$9.88M | 0.03% | 627 |
|
|
2016
Q3 | – | Sell |
-175,594
| Closed | -$3.54M | – | 3092 |
|
|
2016
Q2 | $3.54M | Buy |
175,594
+164,668
| +1,507% | +$4.66M | 0.02% | 940 |
|
|
2016
Q1 | $287K | Buy |
+10,926
| New | +$808K | ﹤0.01% | 2405 |
|
|
2015
Q4 | – | Sell |
-103,660
| Closed | -$18.5M | – | 2669 |
|
|
2015
Q3 | $18.5M | Sell |
103,660
-184,938
| -64% | -$43.1M | 0.09% | 237 |
|
|
2015
Q2 | $64.1M | Sell |
288,598
-202,059
| -41% | -$44.8M | 0.3% | 76 |
|
|
2015
Q1 | $97.4M | Buy |
490,657
+399,073
| +436% | +$70.8M | 0.45% | 31 |
|
|
2014
Q4 | $13.1M | Buy |
+91,584
| New | +$12.3M | 0.07% | 341 |
|
|
2014
Q3 | – | Sell |
-782,433
| Closed | -$98.7M | – | 1753 |
|
|
2014
Q2 | $98.7M | Buy |
782,433
+444,482
| +132% | +$56.7M | 0.44% | 34 |
|
|
2014
Q1 | $44.6M | Buy |
337,951
+331,290
| +4,974% | +$45.3M | 0.24% | 112 |
|
|
2013
Q4 | $782K | Sell |
6,661
-245,105
| -97% | -$26.9M | ﹤0.01% | 1449 |
|
|
2013
Q3 | $26.3M | Buy |
+251,766
| New | +$24.5M | 0.17% | 161 |
|
Other funds holding BHC
PC
GAM
MP
John Overdeck's BHC Position: Q2 2026 in Review
John Overdeck increased its Bausch Health (BHC) stake by 35% in Q2 2026, buying an estimated $2.99M and bringing the position to 2,135,582 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #1487.
John Overdeck first reported a position in BHC in Q3 2013 and has held it in 36 quarters since. The position peaked at $98.7M in Q2 2014. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.
- John Overdeck held 2,135,582 shares of Bausch Health worth $10.5M as of Q2 2026.
- John Overdeck bought 557,421 Bausch Health shares in Q2 2026, an estimated $2.99M.
- Bausch Health made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1487 holding.
- John Overdeck first reported a position in Bausch Health in Q3 2013 and has held it in 36 quarters since.
- John Overdeck's Bausch Health position peaked at $98.7M in Q2 2014.
- 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.